Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia

Author： Hicks C.A.   Ward M.A.   Swettenham J.B.   O'Neill M.J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.381, Iss.2, 1999-09, pp. : 113-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia

By O'Neill M.J.   Hicks C.   Ward M.  

European Journal of Pharmacology, Vol. 310, Iss. 2, 1996-08 ,pp. : 115-122

Elsevier

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1143-1146

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1207-1210

Informa Healthcare

Access to resources Recommend Favorite

The AMPA receptor/Na + channel blocker BIIR 561 CL is protective in a model of global cerebral ischaemia

By Weiser T.   Wienrich M.   Brenner M.   Kubiak R.   Weckesser G.   Palluk R.  

European Journal of Pharmacology, Vol. 421, Iss. 3, 2001-06 ,pp. : 165-170

Elsevier

Access to resources Recommend Favorite

The receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia

By O'Neill M.   Caldwell M.   Earley B.   Canney M.   O'Halloran A.   Kelly J.   Leonard B.E.   Junien J.-L.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite